Pfizer CEO Albert Bourla was one year into his tenure at the helm of the pharmaceutical company when COVID-19 hit. In an interview with strategy+business, Bourla discusses the company’s efforts to codevelop the first COVID-19 vaccine to be approved for use in the U.S., Pfizer’s ongoing transformation, and the necessity to keep striving for big breakthroughs.